Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

351.16 -3.65 (-1.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vertex Pharmaceuticals

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Expert Ratings For Vertex Pharmaceuticals
Vertex Pharmaceuticals (NASDAQ:VRTX) has observed the following analyst ra... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE: 
Via Benzinga
3 Healthcare Stocks That Might Skyrocket When COVID Is Over
Stocks of biotech companies fighting COVID-19 have been great investments over the last two years. What stocks might zoom higher when the pandemic is over? 
Via The Motley Fool
Exposures COVID-19
Understanding Vertex Pharmaceuticals's Unusual Options Activity
On Wednesday, shares of Vertex Pharmaceuticals (NASDAQ:VRTX 
Via Benzinga
Where Vertex Pharmaceuticals Stands With Analysts
Vertex Pharmaceuticals (NASDAQ:VRTX) has observed the following analyst rat... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021
Upgrades BMO Capital upgraded the previous rating for BRP Inc (NASDAQ: 
Via Benzinga
Why Vertex Is Expanding a Gene-Editing Partnership -- and It's not With CRISPR Therapeutics
Vertex plans to work more closely on CRISPR gene editing with a small privately-held biotech. 
Via The Motley Fool
2 of the Best Stocks to Buy Right Now with Just $500
These top stocks are no-brainer buys for your portfolio this month. 
Via The Motley Fool
Moderna And DexCom Lead The Nasdaq-100
U.S. indices had a mixed day of trading Wednesday as investors weigh rising COVID-19 Delta variant cases nationwide. The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) gained 0.17% to... 
Via Benzinga
Exposures COVID-19
The 3 Best Biotech Stocks to Buy Right Now
Let your portfolio reflect your personality. 
Via The Motley Fool
Where Vertex Pharmaceuticals Stands With Analysts
Over the past 3 months, 16 analysts have published their opinion on Vertex Pharmaceuticals (NASDAQ: 
Via Benzinga
3 Cathie Wood Stocks to Buy and Hold for Decades
If you own these companies, the hardest thing to do is sit back and forget about them -- and possibly the best. 
Via The Motley Fool
Vertex Inks Potential $1.2B Gene-Editing Pact With Arbor Biotechnologies
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) and Arbor Biotechnologies have announced a new collaboration to develop ex vivo engineered cell therapies. The new... 
Via Benzinga
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (... 
Via Benzinga
Exposures Product Safety
2 Biopharma Growth Stocks to Buy and Hold for Years
Both of these companies are packed with opportunities. 
Via The Motley Fool
3 Smartest Healthcare Stocks to Buy With $1,000 Right Now
It doesn't take a brainiac to balance risk and reward. 
Via The Motley Fool
3 Beaten-Down Biotech Stocks to Buy Right Now
These biotech stocks might be down, but they're not out. 
Via The Motley Fool
JD.com And Tesla Lead The Nasdaq Lower Tuesday
U.S. indices were trading lower Tuesday amid macro uncertainty due to COVID-19 concerns. Investors also weighed today's Home Depot (NYSE: HD) earnings and a drop in... 
Via Benzinga
Exposures COVID-19
Wall Street Journal Creates A Pitch In Favor Of Royalty Pharma
Drug development, both a lucrative and a risky segment. Royalty Pharma plc (NASDAQ: RPRX) offers a middle ground for its investors. The Company was founded in 1996 and... 
Via Benzinga
Large Cap Biopharma Stocks provide Growth and Value
The S&P 500 Healthcare Index was up 0.53% and biotech still lags in healthcare yet Large Cap Biopharma is doing well YTD. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Buying Vertex Pharmaceuticals Stock Now Could Double Your Money Within 5 Years: Here's How
The big biotech has a clear path to growth if it executes well. 
Via The Motley Fool
5 No-Brainer Stocks to Invest $500 In Right Now
These top-tier companies are perfect to begin or further your trek to financial independence. 
Via The Motley Fool
3 of the Best Stocks You Can Buy With $200 or Less
These three giants of the healthcare sector aren't too big to buy with just a couple hundred bucks. 
Via The Motley Fool
Last Week's Notable Insider Buys: Magnolia Oil & Gas, Vertex Pharmaceuticals
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were picking shares last week in the wake of... 
Via Benzinga
Why CRISPR Therapeutics Stock Fell 25.2% in July
The stock dropped roughly $40 per share over the course of the month. 
Via The Motley Fool
4 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... 
Via Benzinga
A Perspective On The Upcoming Calithera Cystic Fibrosis Read-Out
Calithera is guiding for the market to expect what we believe will be a key data read-out in Q3 from its ongoing CB-280 study involving Cystic Fibrosis. A positive read-out here could see a significant... 
Via Talk Markets
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
Via Benzinga
15 Words From Vertex's CEO That Signal Major Growth Ahead
And they should ease investors' biggest concern. 
Via The Motley Fool
Better Buy: Vertex vs. CRISPR
Vertex might be undervalued, CRISPR Therapeutics might be overvalued, but both are looking for a home run. 
Via The Motley Fool
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.